The world is running out of effective treatments for common conditions.
Long-term open-label extension shows similar safety as vehicle control.
Novel acne treatments have been lacking.
A better understanding of acne epidemiology and risk factors is needed.
The first quantitative review on the association between acne vulgaris and depression/anxiety.
The restrictions are being introduced after a safety review found that high-dose cyproterone medicines may increase risk for meningioma.
System uses severity scores derived from clinical practice.
A promising new topical treatment for patients with papulopustular rosacea.
First approved tazarotene acne treatment available in lotion form.
Nei pazienti che assumono il farmaco si segnalano disturbi depressivi e comportamenti suicidari, ma sono necessarie ulteriori ricerche per determinare se esiste un nesso causale o il disagio deriva dalla malattia cutanea.
Program does not prevent fetal exposures, creates undue burdens, they argue.
New topical therapy option addresses unmet need for patients with moderate-to-severe acne.
Retinoid molecule has shown efficacy for face and trunk acne.
Isotretinoin, used to treat acne, is a known teratogen.
A recent study suggests the risk of meningioma remains increased at least one year after cessation of treatment.
Nearly 18,000 FDA reports in a 10-year span.
Experts offer a framework for care.
